Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
CAR-T Therapy Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The car-t therapy market has experienced substantial expansion in recent years. Its value is projected to rise from $2.98 billion in 2025 to $3.45 billion in 2026, reflecting a compound annual growth rate (CAGR) of 15.9%. Historically, this growth can be ascribed to elements such as limited availability of personalized immunotherapy, the high cost of initial car-t treatments, reliance on hospital-based cell processing, nascent regulatory frameworks, and low patient awareness of car-t therapy.
The car-t therapy market is projected to experience substantial expansion in the coming years, reaching $6.08 billion in 2030 at a compound annual growth rate (CAGR) of 15.2%. This anticipated growth is driven by several factors, including ongoing technological progress in t-cell engineering, increased investment in oncology research, the expansion of commercial car-t manufacturing capabilities, a rise in regulatory approvals, and an increase in collaborations between biopharmaceutical companies and academic institutions. Key trends expected during this period involve the increasing adoption of car-t therapies for hematologic malignancies, the advancement of targeted antigen-specific car-t treatments, a growing emphasis on combination therapy strategies, the expansion of clinical trials and research initiatives, and efforts to lower therapy costs while improving accessibility.
Get A Free Sample Report With In-Depth Market Insights:
CAR-T Therapy Market Expansion Drivers: What’s Shaping Future Growth?
The increasing incidence of cancer is anticipated to fuel the expansion of the CAR-T therapy market in the future. This rise in cancer prevalence signifies a growing count of diagnosed cancer cases within a defined populace or area over time. Such an increase has stimulated both research and investment in various cancer treatments, including cellular immunotherapies. These therapies mark a notable breakthrough in oncology, addressing critical patient needs. As an illustration, in July 2024, the Australian Institute of Health and Welfare, a government body located in Australia, reported that cancer diagnoses there rose from 160,570 in 2022 to 164,694 in 2023, indicating a substantial increase over the year. This trend underscores the expanding burden of cancer nationwide. Consequently, the escalating prevalence of cancer is fostering the growth of the CAR-T therapy market.
CAR-T Therapy Market Segment Analysis Spotlighting Growth Areas
The car-t therapy market covered in this report is segmented –
1) By Type: Monotherapy, Combination Therapy
2) By Target Antigen: CD19, CD22, BCMA, Other Target Antigens
3) By Application: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications
Subsegments:
1) By Monotherapy: CD19-targeted CAR-T Therapy, BCMA-Targeted CAR-T Therapy
2) By Combination Therapy: CAR-T Therapy With Immune Checkpoint Inhibitors, CAR-T Therapy With Other Targeted Therapies, CAR-T Therapy With Chemotherapy Or Radiotherapy
CAR-T Therapy Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies in the CAR-T therapy market are focused on developing sophisticated solutions, such as diagnostic tools, to enhance personalized treatment and improve patient outcomes. Diagnostic tools are defined as instruments, devices, or software utilized to identify and analyze diseases, conditions, or health issues in individuals. These tools include tests, imaging equipment, or lab analyses that offer insights into a patient’s health status, supporting accurate diagnosis and effective treatment planning. For example, in February 2023, Eurofins Viracor, a clinical diagnostic laboratory based in the US, introduced the ExPeCT Expansion and Persistence of CAR T Assay to assist clinicians in understanding how CAR-T therapy is progressing for their patients. This assay provides substantial benefits for monitoring patients receiving CAR T cell therapy. It enables the continuous tracking of CAR T cell expansion and persistence, delivering real-time data crucial for evaluating treatment efficacy and guiding patient management. Moreover, the assay helps pinpoint patients at risk of treatment failure due to inadequate CAR T cell dynamics, facilitating timely interventions that could improve clinical outcomes in hematological malignancies.
CAR-T Therapy Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the car-t therapy market are Gilead Sciences, Novartis AG, Biocon, Gracell Biotechnology Ltd., CARsgen Therapeutics, Takeda Pharmaceutical Company, Astellas Pharma, Innovative Cellular Therapeutics, Cellular Biomedicine Group, PersonGen Biomedicine, Hebei Senlang Biotech, Adaptimmune (UK), Autolus Therapeutics, BioNTech, Cellectis, Celyad, Immatics, Biocad, Celgene Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Amgen, AstraZeneca, Merck, Pfizer, Juno Therapeutics, Allogene Therapeutics, Precision BioSciences, Bellicum, GlaxoSmithKline plc
View The Full CAR-T Therapy Market Report:
CAR-T Therapy Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the CAR-T therapy market in 2025. Western Europe was the second-largest region in the global CAR-T therapy market share. The regions covered in the car-t therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
